Advertisement
News
Advertisement

Aushon in research deal with Peking University Cancer Hospital

Tue, 02/08/2011 - 9:38am
Mass High Tech: The Journal of New England Technology

Microarray and immunoassay company Aushon BioSystems Inc. of Billerica said it has signed a diagnostic development collaboration letter of intent with Peking University Cancer Hospital (PUCH) in Beijing.

The two aim to develop predictive diagnostic markers for liver metastases of colorectal cancer using Aushon’s protein biomarker detection technologies and stratification biomarkers for radio-chemotherapy patients.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading